Recombinant Anti-CD38 × Anti-CD3 Bispecific Antibody (Triplebody) (CAT#: TRIAB-LC001)
The anti-CD3/CD33 antibody targets both CD3 and CD34. By depleting CD38+ cells while minimizing the CRS effects, the bispecific antibody can be potentially used in the treatment of cancers.
Specific Inquiry
Specifications
- Target
- CD38 & CD3
- Type
- Triplebody
- Species Reactivity
- Human
- Target 1
- CD38
- Host Species 1
- Human
- Target 2
- CD3
- Host Species 2
- Human
- Application
- SPR
- Related Disease
- Cancer, Autoimmune disease.
Target
- Target 1
- CD38
- Gene ID
- 952
- UniProt ID
- P28907
- Alternative Names
- CD38; CD38 molecule; T10; ADPRC 1; ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1; cADPr hydrolase 1; CD38 antigen (p45); NAD(+) nucleosidase; ADP-ribosyl cyclase 1; cyclic ADP-ribose hydrolase 1; 2-phospho-ADP-ribosyl cyclase; 2-phospho-cyclic-ADP-ribose transferase; 2-phospho-ADP-ribosyl cyclase/2-phospho-cyclic-ADP-ribose transferase
- Target 2
- CD3
- Alternative Names
- CD3; CD3 T-Cell Co-receptor;CD3D; CD3E; CD3G
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for TRIAB-LC001. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: IF, IP, Neut, FuncS, ELISA, FC, WB
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: IP, IF, FuncS, FC, Neut, ELISA, IHC
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: WB, FuncS, IF, Neut, ELISA, FC, IP
Application: ELISA
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: WB, ELISA, IHC, IP, SPR, FuncS
Application: ELISA, FC, IHC, Neut
Application: Neut, ELISA, WB, SPR, IF, EM
Application: ELISA, Neut, FuncS
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
